Quadrant Capital Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-67
| Closed | -$2.28K | – | 1631 |
|
|
2025
Q1 | $2.28K | Sell |
67
-28
| -29% | -$953 | ﹤0.01% | 2492 |
|
|
2024
Q4 | $3.74K | Buy |
95
+42
| +79% | +$1.65K | ﹤0.01% | 2375 |
|
|
2024
Q3 | $2.49K | Sell |
53
-46
| -46% | -$2.16K | ﹤0.01% | 2457 |
|
|
2024
Q2 | $5.35K | Hold |
99
| – | – | ﹤0.01% | 2278 |
|
|
2024
Q1 | $6.75K | Sell |
99
-36
| -27% | -$2.45K | ﹤0.01% | 2238 |
|
|
2023
Q4 | $8.45K | Sell |
135
-141
| -51% | -$8.83K | ﹤0.01% | 2128 |
|
|
2023
Q3 | $12.5K | Buy |
276
+248
| +886% | +$11.3K | ﹤0.01% | 1902 |
|
|
2023
Q2 | $1.57K | Hold |
28
| – | – | ﹤0.01% | 2458 |
|
|
2023
Q1 | $1.27K | Sell |
28
-124
| -82% | -$5.61K | ﹤0.01% | 2512 |
|
|
2022
Q4 | $6.18K | Buy |
152
+105
| +223% | +$4.27K | ﹤0.01% | 2147 |
|
|
2022
Q3 | $3K | Sell |
47
-4
| -8% | -$255 | ﹤0.01% | 2262 |
|
|
2022
Q2 | $3K | Sell |
51
-111
| -69% | -$6.53K | ﹤0.01% | 2096 |
|
|
2022
Q1 | $10K | Buy |
+162
| New | +$10K | ﹤0.01% | 1635 |
|
|
2021
Q2 | – | Sell |
-5
| Closed | -$1K | – | 2433 |
|
|
2021
Q1 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 2191 |
|